Rebus Holdings Inc (RBSH)

[Hercules1]

$NSPX:


Check this out:




Gilead Sciences appears to be in the lead position in developing an effective treatment for COVID-19.

Its antiviral drug remdesivir is in late-stage clinical studies.



Demand has been so high for the experimental drug in treating patients with severe cases of COVID-19 under emergency-use provisions that the company had to stop accepting new requests for remdesivir with a few exceptions.


This overwhelming demand isn't surprising. World Health Organization (WHO) assistant director-general Bruce Aylward singled out remdesivir in late February as the most promising drug for treating COVID-19.


Since then, Gilead and its experimental coronavirus drug have been featured by many news organizations, garnering a lot of favorable publicity.



*********this is why NSPX is going to skyrocket. NSPX is simply a must own stock.


Furthermore Gilead might just buy out NSPX.



----------------------------------------------------------------




http://inspyrtherapeutics.com/